The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase I study of preoperative continuous 5-FU and sorafenib with external radiation therapy in locally advanced rectal adenocarcinoma.
Gopi Kesaria Prithviraj
No relevant relationships to disclose
Kun Jiang
No relevant relationships to disclose
Xiuhua Zhao
No relevant relationships to disclose
Dung-Tsa Chen
No relevant relationships to disclose
Brian Morse
No relevant relationships to disclose
Ravi Shridhar
No relevant relationships to disclose
Sarah E. Hoffe
No relevant relationships to disclose
David Shibata
No relevant relationships to disclose
Richard D. Kim
Honoraria - Bayer